Chemical Component Summary

Name 1-PHENYL-2-AMINOPROPANE
Identifiers (2R)-1-phenylpropan-2-amine
Formula C9 H13 N
Molecular Weight 135.206  g/mol
Type L-PEPTIDE LINKING
Isomeric SMILES C[C@@H](N)Cc1ccccc1
InChI InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1
InChIKey KWTSXDURSIMDCE-MRVPVSSYSA-N

Chemical Details

Formal Charge 0
Atom Count 23
Chiral Atom Count 1
Chiral Atoms CA
Bond Count 23
Aromatic Bond Count 6
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB00182   (Different stereochemistry)
Name Amphetamine
Groups
  • approved
  • illicit
Description Amphetamine is a chiral compound. The racemic mixture can be divided into its optical antipodes: levo- and dextro-amphetamine. Amphetamine is the parent compound of its own structural class, comprising a broad range of psychoactive derivatives, e.g., MDMA (Ecstasy) and the N-methylated form, methamphetamine. Amphetamine is a homologue of phenethylamine.
Synonyms
  • 1-phenyl-2-aminopropane
  • 1-Phenylpropan-2-amin
  • alpha-Methylbenzeneethaneamine
  • alpha-Methylphenylethylamine
  • Amfetamine
Salts
  • 1-phenyl-2-aminopropane
  • 1-Phenylpropan-2-amin
  • alpha-Methylbenzeneethaneamine
  • alpha-Methylphenylethylamine
  • Amfetamine
Brand Names
  • Adderall
  • Adderall XR
  • Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
  • Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate
  • Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Affected Organism Humans and other mammals
Indication For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.
Pharmacology Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.
Mechanism of action Amphetamines stimulate the release of norepinephrine from central adrenergic receptors. At higher dosages, they cause release of dopamine from the mesocorticolimbic system and the nigrostriatal dopamine systems. Amphetamine may also act as a direct agonist on central 5-HT receptors and may inhibit monoamine oxidase (MAO). In the periphery, amphetamines are believed to cause the release of noradrenaline by acting on the adrenergic nerve terminals and alpha- and beta-receptors. Modulation of serotonergic pathways may contribute to the calming affect. The drug interacts with VMAT enzymes to enhance release of DA and 5-HT from vesicles. It may also directly cause the reversal of DAT and SERT.
Route of administration oral
Categories
  • Adrenergic Agents
  • Adrenergic Uptake Inhibitors
  • Central Nervous System Stimulants
  • Dopamine Agents
  • Dopamine Uptake Inhibitors
ATC-Code N06BA01
AHFS-Code 28:20.04
CAS number 300-62-9
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682